The fight against medicines of dubious origin continues in poor countries

It is common for them people blindly trust when ingesting medicines, But this is usually more reliable only in the cases of those countries belonging to the ‘ first world.

a study performed by the United Nations (HIM-HER-IT) Determined that a 10% of the medicine sold in developing countries so de low quality is included forgeries. That is why it was stressed the importance of improving the detection system i control with respect to the sale of drugs.

The identification of drugs originals can be found at packaging, Which is unique, a factor that prevents the entry of possible forgeries in the legal supply chain. In this way it is unlikely to be a medicine adulterated or risk get into the hands of the population.

there are two key tools to detect those products that have been altered. The first is one identifier with a two-dimensional verification code which contains twenty randomly generated characters, plus the packaging carries the batch number and expiration date. The second is one anti-manipulation system which ensures that the container has not been opened since it is produced until it is sold in the establishments of medical supplies.

these methods have been effective thanks to the joint work of marketers, distributors, pharmacies i private hospitals. In this way it was accounted for 2.7 billion of drugs had unique identifiers, more than 750 million of packaging had been verified and more than 500 million of drugs were marketed for their irregularities.

Thanks to the digitization, The identification system can track at all stages of the evolution of the drug, that is, they are two grains allies which work perfectly to avoid serious consequences.

Despite the state regulations and of international organizations, there are companies who are engaged in developing tools to further improve the detection of fraud. One of them is SICPA, a Swiss company who created a label that allows copies to be determined by identifying the plastics used for the medical devices.

According to the Swiss company, these counterfeit drugs are responsible for that 700,000 people die because of the malaria and the tuberculosis.

And at the time of pandemic, Counterfeits have reached both the diagnostic tests as in European Covid Digital Certificate. Therefore, SICPA confesses that currently these procedures are more necessary than ever, when on these two tools depends the coronavirus spread.

“We are advising Governments i authorities to prevent forgery of passport and coronavirus tests “noted the SICPA Director of Business Development. He added that” should be implemented robust measures to prevent such fraud “.

.Source